Potential and challenges of serotherapy for severe influenza

Affiliations

¹ Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address: leelsn@cuhk.edu.hk.
² Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.

Comment

Nelson Lee et al. Lancet Respir Med. 2017 Aug.

. 2017 Aug;5(8):e27.

doi: 10.1016/S2213-2600(17)30266-7.

¹ Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address: leelsn@cuhk.edu.hk.
² Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.

No abstract available

Comment on

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study.
Beigel JH, Tebas P, Elie-Turenne MC, Bajwa E, Bell TE, Cairns CB, Shoham S, Deville JG, Feucht E, Feinberg J, Luke T, Raviprakash K, Danko J, O'Neil D, Metcalf JA, King K, Burgess TH, Aga E, Lane HC, Hughes MD, Davey RT; IRC002 Study Team. Beigel JH, et al. Lancet Respir Med. 2017 Jun;5(6):500-511. doi: 10.1016/S2213-2600(17)30174-1. Epub 2017 May 15. Lancet Respir Med. 2017. PMID: 28522352 Free PMC article. Clinical Trial.

1. Beigel JH, Tebas P, Elie-Turenne MC, IRC002 Study Team Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study. Lancet Respir Med. 2017;5:500–511. - PMC - PubMed
1. Hui DS, Lee N, Chan PK. Adjunctive therapies and immunomodulatory agents in the management of severe influenza. Antiviral Res. 2013;98:410–416. - PMC - PubMed
1. Lee N, Leo YS, Cao B. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. Eur Respir J. 2015;45:1642–1652. - PMC - PubMed
1. Banoei MM, Vogel HJ, Weljie AM, Canadian Critical Care Translational Biology Group (CCCTBG) Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia. Crit Care. 2017;21:97. - PMC - PubMed
1. Lee N, Wong CK, Chan MCW. Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: a randomized controlled trial. Antiviral Res. 2017;144:48–56. - PubMed